Regarding N-cadherin status, of the 46 N-cadherin-positive carcinomas, 31 tumours (67.4%) were hypervascular; of the 104 N-cadherin-negative carcinomas, 51 tumours (49.0%) were hypervascular. The gene discussed is CDH2; the disease is carcinoma.